0001683168-20-000392.txt : 20200311 0001683168-20-000392.hdr.sgml : 20200311 20200207143121 ACCESSION NUMBER: 0001683168-20-000392 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20200207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20111019 CORRESP 1 filename1.htm

 

 

 

February 7, 2020

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:Phio Pharmaceuticals Corp.
  Registration Statement on Form S-1 (Registration No. 333-234032)
  Concurrence in Acceleration Request

         

 

Ladies and Gentlemen:

 

H.C. Wainwright & Co., LLC (“Wainwright”), as underwriter for the referenced offering, hereby concurs in the request by Phio Pharmaceuticals Corp. that the effective date of the above-referenced registration statement be accelerated to 9:00 a.m. (Eastern Time), or as soon as practicable thereafter, on February 11, 2020 pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.

 

  Very truly yours,
   
  H.C. WAINWRIGHT & CO., LLC
   
  By:  /s/ Edward D. Silvera
    Name: Edward D. Silvera
Title: Chief Operating Officer

 

 

 

GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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end